The Formation of Aberrant Collateral Vessels during Coronary Arteriogenesis in Dog Heart

Publisher： Karger

E-ISSN： 1422-6421|201|2|118-129

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.201, Iss.2, 2016-01, pp. : 118-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metoprolol reduces coronary collateral flow during PTCA

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Pharmaceutical Interventions to Influence Arteriogenesis: New Concepts to Treat Ischemic Heart Disease

Current Medicinal Chemistry, Vol. 13, Iss. 9, 2006-04 ,pp. : 979-987

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease

By Nieminen Tuomo Käähöönen Mika Viiri Leena E Gröönroos Paula Lehtimääki Terho

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1475-1486

Future Medicine

Access to resources Recommend Favorite

Appropriate pharmacology should be initiated before, during and following percutaneous coronary intervention in patients with left ventricular dysfunction or heart failure

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 6, 2007-06 ,pp. : 16-20

Adis International

Access to resources Recommend Favorite

Effect of Beta-Blockade on Heart Rate and VO₂ Kinetics during Recovery in Patients with Coronary Artery Disease

Heart Drug, Vol. 2, Iss. 2, 2002-06 ,pp. : 69-74

Karger

Access to resources Recommend Favorite